Franchise opportunities compared
Amerisourcebergen Drug vs Smallman Tools
Reviewed figures from each brand's Franchise Disclosure Document (FDD), side by side. Each figure carries its FDD year and page. This is not a ranking or recommendation, and the two FDDs may cover different years and location groups.
Initial investment · Item 7
Amerisourcebergen Drug
$5,000 – $12,000
2026 FDD · Item 7 · PDF p. 29Smallman Tools
Not available
Initial franchise fee · Item 5
Amerisourcebergen Drug
Not available
Smallman Tools
$10,000
2025 FDD · Item 5 · PDF p. 3Royalty · Item 6
Amerisourcebergen Drug
Not available
Smallman Tools
Not available
Before you compare
- Amerisourcebergen Drug figures come from its 2026 FDD and Smallman Tools figures from its 2025 FDD, so the years differ.
- Only neither brand has reviewed Item 19 figures here.
Financial commitment
Amerisourcebergen Drug
Smallman ToolsAmerisourcebergen Drug
Smallman Tools
Amerisourcebergen Drug
Smallman Tools
Amerisourcebergen Drug
Smallman Tools
Amerisourcebergen Drug
Smallman Tools
System scale & health
Amerisourcebergen DrugSmallman ToolsAmerisourcebergen Drug
Smallman Tools
Amerisourcebergen Drug
Smallman Tools
Amerisourcebergen Drug
Smallman Tools
Amerisourcebergen Drug
Smallman Tools
Amerisourcebergen Drug
Smallman Tools
Financial performance (Item 19), by location group
Amerisourcebergen DrugNo reviewed Item 19 figures
Smallman ToolsNot disclosed — no Item 19 financial performance representation
Item 19 groups are shown separately and never combined. Revenue or sales figures are not profit. Net outlet change and turnover are Franopolis calculations from the disclosed counts; turnover is a count-based rate, not a measure of owner earnings.
Amerisourcebergen Drug vs Smallman Tools: common questions
- Do Amerisourcebergen Drug and Smallman Tools disclose financial performance (Item 19)?
- Amerisourcebergen Drug has no reviewed Item 19 figures on file; Smallman Tools makes no Item 19 financial performance representation. Different location groups are not directly comparable, and revenue is not profit.
Answers restate the reviewed figures above. Not a ranking or recommendation.
Keep researching
Full Amerisourcebergen Drug report
Every reviewed fee, Item 19 group, outlet table and territory disclosure
Full Smallman Tools report
Every reviewed fee, Item 19 group, outlet table and territory disclosure
